secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001193125-22-175514
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics stockholders elect two Class III directors, ratify KPMG as auditor
--------------------------------------------------------------------------------

- Dr. Emmett Cunningham and Dr. J. Mel Sorensen elected as Class III directors with ~10.6M and ~10.7M votes for, respectively.
- KPMG LLP ratified as independent auditor for FY2022 with 17,167,149 votes for, 46,053 against, and 9,939 abstained.
- Approximately 64.21% of outstanding shares (17,223,141) were present or represented at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312522175514/0001193125-22-175514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312522175514/d315061d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-175514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer